SCHEMBL17868573

SCHEMBL17868573

CCCCCCCCCCC(O)C(O)(O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.50
GPR84 Q9NQS5 7/20 0.46
SPHK1 Q9NYA1 2/20 0.46
FFAR1 O14842 2/20 0.46
LMNA P02545 2/20 0.46
CYP2D6 P10635 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
CETP P11597 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
FFAR4 Q5NUL3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11009471 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL17183842 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL2357639 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL17868580 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL8885222 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL2353545 1.00 FDPS (0.50) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL11142696 0.97 FDPS (0.47) FDPSGPR84SPHK1FFAR1LMNA
SCHEMBL790771 0.90 FDPS (0.43) FDPSGPR84SPHK1FFAR1
Formic Acid SCHEMBL27795878 0.89 FDPS (0.47) FDPSGPR84FFAR1MAPTFFAR4
Formic Acid SCHEMBL28784074 0.87 TRPA1 (0.46) FDPSGPR84FFAR1MAPTFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115197079-A Polyethylene glycol lipid and liposome modified by same, pharmaceutical composition containing liposome, preparation and application of pharmaceutical composition 厦门赛诺邦格生物科技股份有限公司 2022-10-18 CN disclosed
CN-106232575-B Carboxylic ester/urethane compound having polymerizable functional group and fluorine atom group, and method for producing same 优迈特株式会社 2020-02-21 CN disclosed
US-9604918-B2 Carboxylic acid ester/carbamate compound with polymerizable functional group and fluorine atom group, and manufacturing method therefor UNIMATEC CO., LTD. (JP) 2017-03-28 US disclosed
EP-3127897-A1 CARBOXYLIC ESTER / CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR Unimatec Co., Ltd. (JP) 2017-02-08 EP disclosed
US-20160185714-A1 CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR UNIMATEC CO., LTD. (JP) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185714-A1 CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR FFAR2, DECR2, FFAR1 FDPS 659/4885GPR84 347/4885SPHK1 4221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.